Errors in Author Affiliations and Additional Contributions

Abstract

that capacity, he receives a stipend (starting April 11, 2018) and was awarded unexercised stock options (effective April 23, 2018) but owns no stock." My current disclosures as of this writing also include Unum Therapeutics and Bain Capital. All of these relationships are included in the disclosure statement below. I have requested that these articles be amended online to include these disclosures. 12 I appreciate the opportunity to provide these amendments and explain to the readers and editors of JAMA Oncology my previous and current disclosures.